Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients

被引:0
|
作者
O A Catalano
E Nicolai
B R Rosen
A Luongo
M Catalano
C Iannace
A Guimaraes
M G Vangel
U Mahmood
A Soricelli
M Salvatore
机构
[1] University of Naples Parthenope -SDN IRCCS,Department of Radiology
[2] SDN IRCCS,Department of Nuclear Medicine
[3] Athinoula A. Martinos Center for Biomedical Imaging,Department of Radiology
[4] Massachusetts General Hospital,Department of Radiology
[5] Harvard University Medical School,Department of Surgery
[6] University of Naples ‘Federico II’,Department of Radiology
[7] Breast Unit,Department of Radiology
[8] G. Moscati Hospital,Department of Radiology and of Nuclear Medicine
[9] Oregon Health and Sciences University,undefined
[10] MGH Biostatistics Center and MGH Martinos Center,undefined
[11] Harvard University Medical School,undefined
[12] SDN IRCCS,undefined
来源
British Journal of Cancer | 2015年 / 112卷
关键词
PET-CT; PET-MR; skeletal metastases; osseous metastases; breast cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1452 / 1460
页数:8
相关论文
共 50 条
  • [41] FDG PET/CT in detection of disease relapse in patients with breast cancer
    Saranovic, D. P. Sobic
    Pavlovic, S.
    Artiko, V.
    Milojevic, I. Grozdic
    Odalovic, S.
    Obradovic, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S451 - S451
  • [42] FDG PET/CT in a Pregnant Woman With Breast Cancer
    Drouet, Clement
    Vrigneaud, Jean-Marc
    Desmoulins, Isabelle
    Cochet, Alexandre
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (07) : E339 - E341
  • [43] Pitfalls and artifacts of FDG PET/CT in recurrent breast cancer patients
    Laura Evangelista
    Luigi Mansi
    Marta Burei
    Giorgio Saladini
    Clinical and Translational Imaging, 2017, 5 : 169 - 182
  • [44] Metabolomics and FDG-PET-CT in breast cancer
    Chardin, D.
    Pourcher, T.
    Gal, J.
    Bailleux, C.
    Guigonis, J. M.
    Darcourt, J.
    Arnould, L.
    Humbert, O.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2021, 45 (01): : 4 - 12
  • [45] Pitfalls and artifacts of FDG PET/CT in recurrent breast cancer patients
    Evangelista, Laura
    Mansi, Luigi
    Burei, Marta
    Saladini, Giorgio
    CLINICAL AND TRANSLATIONAL IMAGING, 2017, 5 (02) : 169 - 182
  • [46] A comparison of 18F-FDG PET/MR with PET/CT in pulmonary tuberculosis
    Thomas, Benjamin A.
    Molton, James S.
    Leek, Francesca
    Pang, Yan
    Totman, John J.
    Paton, Nicholas I.
    Townsend, David W.
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (11) : 971 - 978
  • [47] Synchorunous Metastases in Recently Diagnosed Breast Cancer: Role of Staging FDG PET/CT
    Ozguven, S.
    Dede, F.
    Ones, T.
    Gulluoglu, B.
    Inanir, S.
    Erdil, T. Y.
    Turoglu, H. T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S353 - S353
  • [48] The Pattern of Metastatic Breast Cancer: A Prospective Head-to-Head Comparison of [18F]FDG-PET/CT and CE-CT
    Gram-Nielsen, Rosa
    Christensen, Ivar Yannick
    Naghavi-Behzad, Mohammad
    Dahlsgaard-Wallenius, Sara Elisabeth
    Jakobsen, Nick Moldrup
    Gerke, Oke
    Jensen, Jeanette Dupont
    Ewertz, Marianne
    Hildebrandt, Malene Grubbe
    Vogsen, Marianne
    JOURNAL OF IMAGING, 2023, 9 (10)
  • [49] FDG-avid sclerotic bone metastases in breast cancer patients: a PET/CT case series
    Bas B. Koolen
    Erik Vegt
    Emiel J. Th. Rutgers
    Wouter V. Vogel
    Marcel P. M. Stokkel
    Cornelis A. Hoefnagel
    Annemarie Fioole-Bruining
    Marie-Jeanne T. F. D. Vrancken Peeters
    Renato A. Valdés Olmos
    Annals of Nuclear Medicine, 2012, 26 : 86 - 91
  • [50] FDG PET and SPECT of bone metastases in breast cancer - Reply
    Uematsu, T
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 185 (06) : 1652 - 1653